Financials
Income statement
| Fiscal date | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.9M | 12.1M | 11.0M | 10.2M |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 3.9M | 4.7M | 3.8M | 2.9M |
| Tax provision | 664K | 882K | 683K | 489K |
| Net income | 3.2M | 3.9M | 3.1M | 2.4M |
| Basic EPS | 1.3 | 1.5 | 1.2 | 0.9 |
| Diluted EPS | 1.3 | 1.5 | 1.2 | 0.9 |
| Basic average shares | 2.5M | 2.5M | 2.5M | 2.5M |
| Diluted average shares | 2.5M | 2.5M | 2.5M | 2.5M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |